Trials / Terminated
TerminatedNCT00202384
Gene Expression in MS Patients Before and During Treatment With Interferon-beta
Gene Expression in MS Patients Before and During Treatment With High-dose Interferon Beta: Prospective Study for the Identification of Predicting Factors of Therapeutic Response.
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 600 (actual)
- Sponsor
- S. Andrea Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
Clinical and experimental evidences suggest that there is a variability in therapeutic response to immunomodulating therapies in Multiple Sclerosis patients. Microarrays is a technology that permits to monitor the expression levels of thousands of genes at a time. The specific aim of this study is to identify predictive factors of therapeutic response in MS patients treated with high-dose Interferon-Beta.
Conditions
Timeline
- Start date
- 2004-11-01
- Primary completion
- 2011-01-01
- Completion
- 2011-01-01
- First posted
- 2005-09-20
- Last updated
- 2018-04-19
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT00202384. Inclusion in this directory is not an endorsement.